Photoswitch Biosciences has assembled an experienced team of scientists, executives, and advisors with drug discovery and development expertise and a proven history of bringing new high-value cell-based assays and instrumentation to market.
Jay Trautman, PhD. Co-founder and CEO. Experienced pharmaceutical research, and life science instrument development, executive. VP Discovery Research & Technology at Cytokinetics; VP/CEO at SEQ/Praelux (through acquisition by Amersham); Scientist at AT&T Bell Labs.
Andrew Blatz, PhD. Co-founder and CSO. Internationally recognized expert in ion channel physiology, drug discovery and life sciences instrument development. VP at Axon Instruments, Inc.
Jonathan Ross, MBA. Co-founder and CFO. Seasoned finance professional with more than twenty years experience in entrepreneurial business management, investment underwriting, venture capital, corporate finance and business development at Convexus Advisors, Babcock & Brown, GATX Capital, Cargill Financial Services and Piper Jaffray.
Contact Us email@example.com